These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27304776)

  • 1. Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality.
    Barry HC
    Am Fam Physician; 2016 Jun; 93(12):1036-7. PubMed ID: 27304776
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of CHARM shows benefit of candesartan on nonfatal MI and CV death in patients with heart failure.
    Cardiovasc J S Afr; 2006; 17(2):95. PubMed ID: 16733606
    [No Abstract]   [Full Text] [Related]  

  • 3. More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis.
    Verdecchia P; Angeli F; Gentile G; Reboldi G
    Hypertension; 2016 Sep; 68(3):642-53. PubMed ID: 27456518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Challenges for Hypertension Treatment.
    Rosas-Peralta M; Jiménez-Genchi GM
    Arch Med Res; 2018 Nov; 49(8):548-557. PubMed ID: 30527899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
    Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
    Bangalore S; Fayyad R; Messerli FH; Laskey R; DeMicco DA; Kastelein JJ; Waters DD
    Am J Cardiol; 2017 Feb; 119(3):379-387. PubMed ID: 27939230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis.
    Reboldi G; Angeli F; Gentile G; Verdecchia P
    Eur J Intern Med; 2022 Jul; 101():49-55. PubMed ID: 35397950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
    Thijs L; Richart T; de Leeuw PW; Kuznetsova T; Grodzicki T; Kawecka-Jaszcz K; O'Brien E; Redón J; Birkenhäger WH; Fagard R; Staessen JA
    J Hypertens; 2010 Apr; 28(4):865-74. PubMed ID: 20051905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure in heart failure: a love-hate relationship.
    Pfeffer MA
    J Am Coll Cardiol; 2007 Jan; 49(1):40-2. PubMed ID: 17207720
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients.
    Reboldi G; Gentile G; Angeli F; Ambrosio G; Mancia G; Verdecchia P
    J Hypertens; 2011 Jul; 29(7):1253-69. PubMed ID: 21505352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A; Battegay E
    Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada.
    Campbell NR; Brant R; Johansen H; Walker RL; Wielgosz A; Onysko J; Gao RN; Sambell C; Phillips S; McAlister FA;
    Hypertension; 2009 Feb; 53(2):128-34. PubMed ID: 19114646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.
    Bangalore S; Kumar S; Volodarskiy A; Messerli FH
    Heart; 2013 May; 99(9):601-13. PubMed ID: 22914531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uneven sex distribution in the cardiovascular trials--an exaggerated problem].
    Melander H; Rastad JA
    Lakartidningen; 2006 Jun 8-13; 103(23):1856-9. PubMed ID: 16838599
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.
    Hao G; Wang Z; Guo R; Chen Z; Wang X; Zhang L; Li W
    BMC Cardiovasc Disord; 2014 Oct; 14():148. PubMed ID: 25344747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
    Bejan-Angoulvant T; Saadatian-Elahi M; Wright JM; Schron EB; Lindholm LH; Fagard R; Staessen JA; Gueyffier F
    J Hypertens; 2010 Jul; 28(7):1366-72. PubMed ID: 20574244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid blood pressure lowering may improve haemorrhagic stroke outcomes.
    BMJ; 2013 Jun; 346():f3584. PubMed ID: 23737400
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.
    Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Cavazzini C; Furberg CD
    Lancet; 2000 Dec; 356(9246):1949-54. PubMed ID: 11130522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.